Pub Date : 2024-12-01Epub Date: 2024-04-30DOI: 10.1017/S0022215124000859
Joseph Smith, Anita Smith, Karen McInally, Paul Kirkland
Introduction: Dysphagia can lead to morbidity including weight loss and aspiration pneumonia. Effective triage of patients and streamlining of pathways to expedite diagnosis and treatment is therefore imperative.
Objectives: The goals of this research were to measure the referral to treatment time for dysphagia patients in a newly established pathway and compare with existing UK national and local referral to treatment times, and to evaluate patient feedback.
Methods: Speech and language therapy advanced clinical practitioners were trained in nasendoscopy and assessment of swallow. Referral to treatment times were measured and patient satisfaction questionnaires completed.
Results: A decrease in triage to treatment time (from 24 to 6 weeks). Patients reported high understanding of the condition and minimal discomfort during assessments. Radiation exposure was reduced (2 per cent of patients undergoing soluble contrast swallows, previously 100 per cent).
Conclusion: The new pathway expedites treatment and achieves high patient satisfaction. It empowers speech and language therapy in efficiently managing low-complexity cases and supports multidisciplinary care for dysphagia patients.
{"title":"Our experience of a speech and language therapist-led swallow disorder clinic.","authors":"Joseph Smith, Anita Smith, Karen McInally, Paul Kirkland","doi":"10.1017/S0022215124000859","DOIUrl":"10.1017/S0022215124000859","url":null,"abstract":"<p><strong>Introduction: </strong>Dysphagia can lead to morbidity including weight loss and aspiration pneumonia. Effective triage of patients and streamlining of pathways to expedite diagnosis and treatment is therefore imperative.</p><p><strong>Objectives: </strong>The goals of this research were to measure the referral to treatment time for dysphagia patients in a newly established pathway and compare with existing UK national and local referral to treatment times, and to evaluate patient feedback.</p><p><strong>Methods: </strong>Speech and language therapy advanced clinical practitioners were trained in nasendoscopy and assessment of swallow. Referral to treatment times were measured and patient satisfaction questionnaires completed.</p><p><strong>Results: </strong>A decrease in triage to treatment time (from 24 to 6 weeks). Patients reported high understanding of the condition and minimal discomfort during assessments. Radiation exposure was reduced (2 per cent of patients undergoing soluble contrast swallows, previously 100 per cent).</p><p><strong>Conclusion: </strong>The new pathway expedites treatment and achieves high patient satisfaction. It empowers speech and language therapy in efficiently managing low-complexity cases and supports multidisciplinary care for dysphagia patients.</p>","PeriodicalId":16293,"journal":{"name":"Journal of Laryngology and Otology","volume":" ","pages":"1130-1132"},"PeriodicalIF":1.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140870540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01Epub Date: 2024-10-21DOI: 10.1017/S0022215124001026
Edward Balai, Emilie Ac Dronkers, Chadwan A Yaghchi, Dorothy Gujral, Guri Sandhu, Aphrodite Iacovidou
Objective: Recurrent respiratory papillomatosis is a rare disease characterised by growth of papilloma within the respiratory tract. The disease course is variable but can require frequent surgical interventions alongside adjuvant medical treatments. There is no definitive curative treatment or gold-standard guidelines for management. We aimed to evaluate current and potential future adjuvant treatments and propose a management guideline for adult patients.
Methods: Relevant articles were identified through searching databases, reference lists and grey literature.
Results: Systemic bevacizumab appears to be the most effective adjuvant treatment currently available. However, intralesional cidofovir also achieves a high complete-response rate in adults and the Gardasil vaccine demonstrates preventative and therapeutic value. The INO-3107 DNA vaccine is a promising potential future adjuvant treatment.
Conclusions: This review provides a detailed examination of current and potential future adjuvant treatments. Based on the literature, we have developed a management guideline for adult patients with recurrent respiratory papillomatosis.
{"title":"Adjuvant treatments for recurrent respiratory papillomatosis: a descriptive review and proposed management guideline in adults.","authors":"Edward Balai, Emilie Ac Dronkers, Chadwan A Yaghchi, Dorothy Gujral, Guri Sandhu, Aphrodite Iacovidou","doi":"10.1017/S0022215124001026","DOIUrl":"10.1017/S0022215124001026","url":null,"abstract":"<p><strong>Objective: </strong>Recurrent respiratory papillomatosis is a rare disease characterised by growth of papilloma within the respiratory tract. The disease course is variable but can require frequent surgical interventions alongside adjuvant medical treatments. There is no definitive curative treatment or gold-standard guidelines for management. We aimed to evaluate current and potential future adjuvant treatments and propose a management guideline for adult patients.</p><p><strong>Methods: </strong>Relevant articles were identified through searching databases, reference lists and grey literature.</p><p><strong>Results: </strong>Systemic bevacizumab appears to be the most effective adjuvant treatment currently available. However, intralesional cidofovir also achieves a high complete-response rate in adults and the Gardasil vaccine demonstrates preventative and therapeutic value. The INO-3107 DNA vaccine is a promising potential future adjuvant treatment.</p><p><strong>Conclusions: </strong>This review provides a detailed examination of current and potential future adjuvant treatments. Based on the literature, we have developed a management guideline for adult patients with recurrent respiratory papillomatosis.</p>","PeriodicalId":16293,"journal":{"name":"Journal of Laryngology and Otology","volume":" ","pages":"1133-1143"},"PeriodicalIF":1.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142467688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01Epub Date: 2025-01-15DOI: 10.1017/S0022215124002317
Jonathan Fishman, Edward W Fisher
{"title":"Tinnitus and dementia risk, adjuvant treatments for recurrent respiratory papillomatosis and is frontal sinus pain a useful marker of chronic frontal sinusitis?","authors":"Jonathan Fishman, Edward W Fisher","doi":"10.1017/S0022215124002317","DOIUrl":"https://doi.org/10.1017/S0022215124002317","url":null,"abstract":"","PeriodicalId":16293,"journal":{"name":"Journal of Laryngology and Otology","volume":"138 12","pages":"1119"},"PeriodicalIF":1.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142983814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01Epub Date: 2024-10-21DOI: 10.1017/S0022215124001105
Amarkumar Dhirajlal Rajgor, Josh Cowley, Colin Gillespie, Chang Woo Lee, James O'Hara, Muhammad Shahid Iqbal, David Winston Hamilton
Background: Our centre (Freeman Hospital, Newcatle Upon Tyne NHS Trust) has favoured primary surgery over chemoradiotherapy for specific advanced laryngeal cancer patients (e.g. large-volume tumours, airway compromise, significant dysphagia, T4 disease). This study reports the survival outcomes for a modern, high-volume head and neck centre favouring surgical management to determine whether this approach improves survival.
Method: Retrospective analysis of patient data over a seven-year period from a tertiary cancer centre.
Results: In total, 121 patients were identified with T3 (n = 76) or T4 (n = 45) laryngeal cancer (mean follow up 2.9 years). In the cohort treated with curative intent (n = 104, 86.0 per cent), the 2- and 5-year estimated disease-specific survival rates were 77.9 and 64.1 per cent. chemoradiotherapy had the highest 2-year disease-specific survival (92.5 per cent), followed by surgery with adjuvant therapy (81.8 per cent), radiotherapy alone (75 per cent) and surgery alone (72.4 per cent).
Conclusion: For a centre favouring primary surgery for certain advanced laryngeal cancers, the disease-specific survival appears no higher than that found in the published literature. To enhance survival, future research should focus on precision medicine to define treatment pathways in this disease.
背景:我们的中心(Freeman医院,Newcatle Upon Tyne NHS Trust)对于特定的晚期喉癌患者(如大体积肿瘤,气道受损,严重吞咽困难,T4疾病)更倾向于初级手术而不是放化疗。本研究报告了现代大容量头颈部中心的生存结果,以确定手术治疗是否能提高生存率。方法:回顾性分析某三级肿瘤中心7年的患者资料。结果:121例患者确诊为T3(76例)或T4(45例)喉癌(平均随访2.9年)。在以治疗目的治疗的队列中(n = 104, 86.0%), 2年和5年的估计疾病特异性生存率分别为77.9%和64.1%。放化疗的2年疾病特异性生存率最高(92.5%),其次是手术辅助治疗(81.8%),单独放疗(75%)和单独手术(72.4%)。结论:对于一个支持对某些晚期喉癌进行原发性手术的中心来说,疾病特异性生存率似乎并不高于已发表的文献。为了提高生存率,未来的研究应侧重于精准医学,以确定该疾病的治疗途径。
{"title":"Outcomes of the modern management approach for locally advanced (T<sub>3</sub>-T<sub>4</sub>) laryngeal cancer: a retrospective cohort study.","authors":"Amarkumar Dhirajlal Rajgor, Josh Cowley, Colin Gillespie, Chang Woo Lee, James O'Hara, Muhammad Shahid Iqbal, David Winston Hamilton","doi":"10.1017/S0022215124001105","DOIUrl":"10.1017/S0022215124001105","url":null,"abstract":"<p><strong>Background: </strong>Our centre (Freeman Hospital, Newcatle Upon Tyne NHS Trust) has favoured primary surgery over chemoradiotherapy for specific advanced laryngeal cancer patients (e.g. large-volume tumours, airway compromise, significant dysphagia, T<sub>4</sub> disease). This study reports the survival outcomes for a modern, high-volume head and neck centre favouring surgical management to determine whether this approach improves survival.</p><p><strong>Method: </strong>Retrospective analysis of patient data over a seven-year period from a tertiary cancer centre.</p><p><strong>Results: </strong>In total, 121 patients were identified with T<sub>3</sub> (<i>n</i> = 76) or T<sub>4</sub> (<i>n</i> = 45) laryngeal cancer (mean follow up 2.9 years). In the cohort treated with curative intent (<i>n</i> = 104, 86.0 per cent), the 2- and 5-year estimated disease-specific survival rates were 77.9 and 64.1 per cent. chemoradiotherapy had the highest 2-year disease-specific survival (92.5 per cent), followed by surgery with adjuvant therapy (81.8 per cent), radiotherapy alone (75 per cent) and surgery alone (72.4 per cent).</p><p><strong>Conclusion: </strong>For a centre favouring primary surgery for certain advanced laryngeal cancers, the disease-specific survival appears no higher than that found in the published literature. To enhance survival, future research should focus on precision medicine to define treatment pathways in this disease.</p>","PeriodicalId":16293,"journal":{"name":"Journal of Laryngology and Otology","volume":" ","pages":"1154-1160"},"PeriodicalIF":1.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11735189/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142467730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01Epub Date: 2024-12-04DOI: 10.1017/S0022215124001178
Xi Zhang, Min Yan, Qicheng Deng, Ling Yang
Objective: This systematic review aims to synthesise findings from randomised, controlled trials and assess the efficacy and safety of radiofrequency ablation in treating allergic rhinitis.
Methods: A thorough search was conducted across PubMed, the Cochrane Library, Embase, Web of Science, China National Knowledge Infrastructure, WanFang, Chinese Scientific Journal, and Chinese Biomedical Literature databases from their inception until October 2023. The primary outcome measure was the total effective rate, with secondary outcomes including adverse events.
Results: This review included 15 randomised, controlled trials involving 1430 patients. The pooled analysis revealed a statistically significant effect on the total effective rate (odds ratio = 3.27, 95 per cent confidence interval = 2.37 to ~4.51). However, no statistical significance was observed in adverse events (odds ratio = 1.18, 95 per cent confidence interval = 0.67 to ~2.08).
Conclusions: Based on the analytical results, radiofrequency ablation emerges as an efficacious and safe treatment modality for allergic rhinitis. Given the constraints posed by a limited sample size, it is imperative that forthcoming clinical trials adhere rigorously to the gold standard of randomised, controlled trials for the purpose of corroborating these conclusions.
{"title":"The efficacy and safety of radiofrequency ablation for allergic rhinitis: a systematic review and meta-analysis.","authors":"Xi Zhang, Min Yan, Qicheng Deng, Ling Yang","doi":"10.1017/S0022215124001178","DOIUrl":"10.1017/S0022215124001178","url":null,"abstract":"<p><strong>Objective: </strong>This systematic review aims to synthesise findings from randomised, controlled trials and assess the efficacy and safety of radiofrequency ablation in treating allergic rhinitis.</p><p><strong>Methods: </strong>A thorough search was conducted across PubMed, the Cochrane Library, Embase, Web of Science, China National Knowledge Infrastructure, WanFang, Chinese Scientific Journal, and Chinese Biomedical Literature databases from their inception until October 2023. The primary outcome measure was the total effective rate, with secondary outcomes including adverse events.</p><p><strong>Results: </strong>This review included 15 randomised, controlled trials involving 1430 patients. The pooled analysis revealed a statistically significant effect on the total effective rate (odds ratio = 3.27, 95 per cent confidence interval = 2.37 to ~4.51). However, no statistical significance was observed in adverse events (odds ratio = 1.18, 95 per cent confidence interval = 0.67 to ~2.08).</p><p><strong>Conclusions: </strong>Based on the analytical results, radiofrequency ablation emerges as an efficacious and safe treatment modality for allergic rhinitis. Given the constraints posed by a limited sample size, it is imperative that forthcoming clinical trials adhere rigorously to the gold standard of randomised, controlled trials for the purpose of corroborating these conclusions.</p>","PeriodicalId":16293,"journal":{"name":"Journal of Laryngology and Otology","volume":" ","pages":"1120-1129"},"PeriodicalIF":1.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142769710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01Epub Date: 2024-10-22DOI: 10.1017/S0022215124001117
Alexander Charlton, Raul Simon, Karthika Shanthakunalan, Anthony Simons
Objective: This retrospective study comprehensively assesses clinical characteristics, management, outcomes, and complications of deep neck space infections in adults at a UK ear, nose and throat tertiary centre.
Methods: Adult deep neck space infection patients from April 2019 to March 2021 were retrospectively reviewed using health records and picture archiving and communication system data. Demographics, presentation, microbiology, treatment, complications, and outcomes were analysed.
Results: Fifty-three patients (mean age: 53.8 years, M:F ratio 1.5:1) were studied. Deep neck space infections were polymicrobial in 29.4 per cent, with Streptococcus milleri group (64.7 per cent) occurring most frequently. Complications occurred in 20.8 per cent, including mediastinitis (13.2 per cent) and Lemierre's syndrome (7.5 per cent). Mortality was 5.7 per cent. Treatment included intensive care admission (32.1 per cent), tracheostomy (15.1 per cent), medical management alone (39.6 per cent), bedside peritonsillar abscess drainage (18.9 per cent), transcervical drainage (28.3 per cent), transoral drainage (13.2 per cent), and hot tonsillectomy (5.7 per cent). Patient age correlated with length of stay.
Conclusion: The study highlights deep neck space infection complexity, emphasising tailored management, effective antibiotics, and frequency and severity of complications. Comprehensive understanding of deep neck space infections can improve care and outcomes.
{"title":"Deep neck space infections: a UK centre, two-year, retrospective review of 53 cases.","authors":"Alexander Charlton, Raul Simon, Karthika Shanthakunalan, Anthony Simons","doi":"10.1017/S0022215124001117","DOIUrl":"10.1017/S0022215124001117","url":null,"abstract":"<p><strong>Objective: </strong>This retrospective study comprehensively assesses clinical characteristics, management, outcomes, and complications of deep neck space infections in adults at a UK ear, nose and throat tertiary centre.</p><p><strong>Methods: </strong>Adult deep neck space infection patients from April 2019 to March 2021 were retrospectively reviewed using health records and picture archiving and communication system data. Demographics, presentation, microbiology, treatment, complications, and outcomes were analysed.</p><p><strong>Results: </strong>Fifty-three patients (mean age: 53.8 years, M:F ratio 1.5:1) were studied. Deep neck space infections were polymicrobial in 29.4 per cent, with <i>Streptococcus milleri</i> group (64.7 per cent) occurring most frequently. Complications occurred in 20.8 per cent, including mediastinitis (13.2 per cent) and Lemierre's syndrome (7.5 per cent). Mortality was 5.7 per cent. Treatment included intensive care admission (32.1 per cent), tracheostomy (15.1 per cent), medical management alone (39.6 per cent), bedside peritonsillar abscess drainage (18.9 per cent), transcervical drainage (28.3 per cent), transoral drainage (13.2 per cent), and hot tonsillectomy (5.7 per cent). Patient age correlated with length of stay.</p><p><strong>Conclusion: </strong>The study highlights deep neck space infection complexity, emphasising tailored management, effective antibiotics, and frequency and severity of complications. Comprehensive understanding of deep neck space infections can improve care and outcomes.</p>","PeriodicalId":16293,"journal":{"name":"Journal of Laryngology and Otology","volume":" ","pages":"1161-1169"},"PeriodicalIF":1.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142467716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-15DOI: 10.1017/S0022215124002172
Bhargavi Chandrasekar, Alexandra Bell, Andrew Kinshuck
{"title":"Prevalence and risk factors for dysplasia and malignancy in a large cohort of patients with recurrent respiratory papillomatosis.","authors":"Bhargavi Chandrasekar, Alexandra Bell, Andrew Kinshuck","doi":"10.1017/S0022215124002172","DOIUrl":"10.1017/S0022215124002172","url":null,"abstract":"","PeriodicalId":16293,"journal":{"name":"Journal of Laryngology and Otology","volume":" ","pages":"1-16"},"PeriodicalIF":1.1,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142622295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-15DOI: 10.1017/S002221512400224X
Petr Daniel Kovarik, Jakub Cvek, Rahul Patil, Charles Kelly, Malcolm Jackson, Laura McKenzie, Nick West, Nicholas Willis, Josef Paul Kovarik, Muhammad Shahid Iqbal
{"title":"Squamous cell carcinoma of the posterior pharyngeal wall: A comparative analysis of oropharyngeal origin versus hypopharyngeal origin.","authors":"Petr Daniel Kovarik, Jakub Cvek, Rahul Patil, Charles Kelly, Malcolm Jackson, Laura McKenzie, Nick West, Nicholas Willis, Josef Paul Kovarik, Muhammad Shahid Iqbal","doi":"10.1017/S002221512400224X","DOIUrl":"10.1017/S002221512400224X","url":null,"abstract":"","PeriodicalId":16293,"journal":{"name":"Journal of Laryngology and Otology","volume":" ","pages":"1-17"},"PeriodicalIF":1.1,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142622298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-14DOI: 10.1017/S0022215124002202
Nehal Lal, H C Taneja, Ravi Meher, Raman Sharma
{"title":"\"COMPARISON OF TRAGAL PERICHONDRIUM WITH CUBISM GRAFT IN ENDOSCOPIC TYMPANOPLASTY IN SMALL TO MEDIUM SIZE TYMPANIC MEMBRANE PERFORATIONS\".","authors":"Nehal Lal, H C Taneja, Ravi Meher, Raman Sharma","doi":"10.1017/S0022215124002202","DOIUrl":"https://doi.org/10.1017/S0022215124002202","url":null,"abstract":"","PeriodicalId":16293,"journal":{"name":"Journal of Laryngology and Otology","volume":" ","pages":"1-9"},"PeriodicalIF":1.1,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142622143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-14DOI: 10.1017/S0022215124002196
Loic Hayois, Peter Andrews, Samuel C Leong, Rishi Sharma, Neil Tan
{"title":"Post-operative management following endoscopic sinus surgery in the UK: a survey of The British Rhinological Society.","authors":"Loic Hayois, Peter Andrews, Samuel C Leong, Rishi Sharma, Neil Tan","doi":"10.1017/S0022215124002196","DOIUrl":"https://doi.org/10.1017/S0022215124002196","url":null,"abstract":"","PeriodicalId":16293,"journal":{"name":"Journal of Laryngology and Otology","volume":" ","pages":"1-21"},"PeriodicalIF":1.1,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142622280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}